Market Performance: A Soft Start on Listing Day
The Park Medi World IPO listing today unfolded on a subdued note in the Indian stock market. After a closely watched public issue, the stock entered the secondary market with mild pressure, reflecting cautious sentiment among investors on debut.
On December 17, the Park Medi World share price was listed at:
- ₹158 on NSE, down 2.5% from the issue price of ₹162
- ₹155.60 on BSE, marking a sharper decline of 3.95%
The muted opening indicated limited buying interest at higher levels, even as trading activity picked up soon after listing.
Main News: How the IPO Debut Played Out
The Park Medi World IPO made its debut after concluding its public issue earlier in the month. While the IPO saw strong participation during the bidding phase, the listing day performance remained under pressure across both major exchanges.
The gap between the issue price and listing price highlighted cautious market positioning, especially in a session where investors appeared selective toward new listings.
IPO Subscription Snapshot
Despite the weak debut, the Park Medi World IPO recorded solid demand during the three-day bidding period.
- Overall subscription: 8.53 times
- Total bids received: 33.88 crore shares
- Shares on offer: 3.97 crore
Category-wise subscription:
- Retail investors: 3.32 times
- Non-institutional investors (NIIs): 15.93 times
- Qualified institutional buyers (QIBs): 12.07 times
The numbers pointed to strong primary market interest, particularly from institutional and non-institutional participants.
Park Medi World IPO Details
The IPO was launched to raise ₹920 crore, comprising:
- Fresh issue: 4.75 crore shares aggregating ₹770 crore
- Offer for sale (OFS): 0.93 crore shares worth ₹150 crore
The Park Medi World IPO price band was fixed at ₹154–₹162 per share.
Key dates:
- IPO open: December 10
- IPO close: December 12
- Allotment finalised: December 15
- Listing date: December 17
Ahead of the issue opening, the company raised ₹276 crore from anchor investors on December 9.
Applications were accepted in lots of 92 shares, requiring a minimum retail investment of ₹14,904.
Use of IPO Proceeds
As outlined in the offer documents, proceeds from the fresh issue are planned to be used for:
- Repayment of borrowings: ₹380 crore
- New hospital development and expansion: ₹60.50 crore
- Purchase of medical equipment: ₹27.46 crore
- General corporate purposes and potential inorganic expansion
Company Details: Park Medi World at a Glance
Park Medi World is a major private healthcare operator in North India. As of March 31, 2025, it is:
- The second-largest private hospital operator in North India
- The largest private hospital chain in Haryana
The company operates 14 NABH-accredited multi-super speciality hospitals under the Park brand.
Its infrastructure has expanded rapidly:
- Beds in March 2023: 2,550
- Beds by September 2025: 3,250
Additional hospitals are under development in Ambala, Panchkula, Rohtak, New Delhi, Gorakhpur, and Kanpur.
Financial Performance Snapshot
Park Medi World reported steady revenue growth and improved profitability in recent years.
- Revenue (FY25): ₹1,426 crore
- Revenue (FY24): ₹1,263 crore
- Revenue (FY23): ₹1,272 crore
- Net profit (FY25): ₹213 crore
- Net profit (FY24): ₹152 crore
- Net profit (FY23): ₹228 crore
The FY25 performance showed a recovery in profitability compared to the previous year, supported by expanding operations.
Summary: A Cautious Listing Despite Strong IPO Demand
The Park Medi World IPO listing saw shares debut below the issue price on both NSE and BSE. While the IPO attracted strong subscription across investor categories, the listing-day performance reflected a careful market approach toward new healthcare listings.
The debut added another chapter to ongoing IPO listing today developments, showing how strong primary market demand does not always translate into immediate secondary market gains, especially in a selective trading environment.
Easy & quick
Leave A Comment?